HEPATIC FIBROSIS
Clinical trials for HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Vitamin B3 shows promise against fatty liver damage
Disease control Recruiting nowThis study tests whether nicotinamide (a form of vitamin B3) can stop or reverse liver scarring in people with fatty liver disease and obesity. Thirty adults with liver fibrosis will take either nicotinamide or a placebo daily for one year. Researchers will measure changes in liv…
Matched conditions: HEPATIC FIBROSIS
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
Simple blood test could catch silent liver disease early
Knowledge-focused Recruiting nowThis study is testing a way to find early liver scarring (fibrosis) in people who don't have symptoms yet. Doctors will use a simple blood test called FIB-4, followed by a more detailed test if needed. The goal is to see if this approach helps catch serious liver problems earlier…
Matched conditions: HEPATIC FIBROSIS
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC